The paper does not provide a list of antigens with strong expression on IDH-wildtype glioblastoma cancer cells. However, it does mention the following antigens in the context of immunotherapy or tumor targeting:

- PD1 (PDCD1)
- B7-H3 (CD276)
- CD44
- CD48
- NRP1

These antigens are not discussed in relation to their expression levels across different cancer types.
